Alirocumab in Dexamethasone-Induced Metabolic Syndrome: Therapeutic Benefits and Potential Hepatic Risks through RXR-α / p-AKT Modulation

Saudi Toxicology Journal (STJ) | Vol. 1 | Issue 3 | 2025

DOI: https://doi.org/10.70957/uqu.edu.sa/s.toxicology.s/stj.2025.1.3.1

Evolocumab ameliorates myocardial fibrosis and improves metabolic syndrome–induced cardiac dysfunction in rats via inhibiting PCSK9/NLRP3 inflammasome and Caspase-1 / IL-1β pathways.

European Journal of Pharmacology | Issue in press | 2025

DOI: https://doi.org/10.1016/j.ejphar.2025.177499

Anti-Candidal Activity of Reboxetine and Sertraline Antidepressants: Effects on Pre-Formed Biofilms

Antibiotics | 2023

DOI: https://doi.org/10.3390/antibiotics12050881

The Combined Effect of Licorice Extract and Bone Marrow Mesenchymal Stem Cells on Cisplatin-Induced Hepatocellular Damage in Rats

Metabolites | Vol. 13 | Issue 1 | 2023

DOI: https://doi.org/10.3390/metabo13010094

Trevo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities

Annals of Neurosciences | Vol. 29 | Issue 2-3 | 2022

DOI: https://doi.org/10.1177/09727531221077642

Computational study of the therapeutic potentials of a new series of imidazole derivatives against

Journal of Pharmacological Sciences | Vol. 147 | Issue 1 | 2021

DOI: https://doi.org/10.1016/j.jphs.2021.05.004

Effect of Canagliflozin, an SGLT2 Inhibitor, in Comparison with Atorvastatin on Dexamethasone-Induced Hepatic Steatosis in Albino Rats

Current Drug Therapy | Vol. 15 | Issue 3 | 2020

DOI: https://doi.org/10.2174/1574885514666191007094424